Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Check Note
Ver. Summary Created by Modification Content Size Created at Operation
1 + 2403 word(s) 2403 2021-08-25 08:26:21 |
2 update references and layout + 24 word(s) 2427 2021-09-10 09:53:41 |
Preclinical Urethral Tissue Engineering Studies
Upload a video

While the reasons the positive results obtained in preclinical studies for urethral repair have not been reproduced in the subsequent clinical trials are complex, poorly designed experiments and a lack of quality in reporting might be some of the main reasons that hinder clinical translation. However, the quality of reporting in preclinical urethral tissue engineering studies remains unclear. Moreover, it is unknown if the quality of reporting has improved as a consequence of the introduction of the ARRIVE guidelines.

urethral strictures hypospadias animal experiments quality assessment translational research
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 291
Revisions: 2 times (View History)
Update Date: 10 Sep 2021
Table of Contents

    1. Introduction of Urethral Repair

    Urethral repair is considered a complex task for urologists, where the greatest demanding clinical needs occur following urethral strictures in adults and congenital anomalies (e.g., hypospadias) in children. In adults, it has been estimated that 0.1% of men above the age of 65 years suffer from urethral strictures, which can occur secondary to different etiologies, including pelvic trauma, lichen sclerosus, non-specific urethritis, and iatrogenic injuries [1]. The selection of the surgical management approach is based on the extent and etiology of the stricture. For distal strictures, the approach includes initial endoscopic urethrotomy or dilatation, and subsequent surgical interventions are usually reserved to when the urethrotomy fails, or the stricture recurs. For short strictures, anastomotic urethroplasty generally solves the problem. The preferred surgical approach in strictures larger than 1 cm or complicated cases is replacement urethroplasty using an autologous graft that can be used either as a patch or in full circumference. Although different sources of grafting material have been tried, buccal mucosa is currently considered the preferred option owing to its inherent lack of hair, compatibility with a moist environment, and a low rate of donor site morbidity [2]. In pediatric patients, hypospadias has an incidence of around 1 per 300 male newborns, where the shortage of the urethra is a surgical challenge [3]. The currently practiced surgical techniques for the management of these diseases have high complication rates and need specific skills to be applied optimally [3][4][5][6][7]. For both adult and pediatric patients, there is a wide consensus about the need for further consolidated basic research, including the use of tissue engineering and regenerative medicine techniques for urethral reconstruction [8][9][10][11].

    Among the various animal models used to investigate male urethral repair strategies, the rabbit model has been by far the most popular choice [10][12][13]. The male rabbit’s urethra is easily accessible and possesses remarkable histological and functional similarities to the human urethra, such as a thin epithelial layer supported by the highly vascularized spongiosum and a urethral smooth muscle layer contributing to the urethral tone [14][15][16][17][18]. In addition, the size of an adult rabbit’s urethra is comparable to that of a male infant, allowing the use of transurethral instrumentation and procedures employed in pediatric surgery. Studies using rabbits have, therefore, been instrumental in demonstrating the feasibility of urethral reconstruction using a variety of synthetic and natural polymeric matrices [8][9][10]. Several approaches have been under scrutiny, most of which have shown the ability to support the recovery of normal urethral architecture and function, with a similar performance to that of autologous tissue grafts. However, a recent meta-analysis of 63 preclinical and 13 human studies of tissue engineering for urethral reconstruction revealed that the efficacy of these approaches could not be defined because of the lack of well-controlled preclinical investigations. The study also revealed that the promising preclinical results obtained using cell-laden matrices could surprisingly not be translated into the clinical studies [10].

    Studies in other fields have also shown a number of difficulties in assessing the efficacy or translating the results from animal research to the clinical context. The issues include physiological variations among species and strains [19], lack of randomization and blinding [20], inadequate reporting of methods and materials, and the publication bias of not describing trials with adverse or indeterminate outcomes, which derivate to an overestimation of the impact of a therapy [21]. In 2009, the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) examined the nature of the reporting, experimental design, and statistical analysis in 271 published preclinical experiments. The survey showed several shortcomings in study design, statistical analysis, and reporting, and inspired the publication of the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines in 2010 [22][23][24]. The checklist consists of 20 items that cover the critical data to be reported in a preclinical scientific paper. Despite increased awareness in the scientific community, however, which includes the adoption of the guidelines by more than 1000 scientific journals, the quality of reporting has not significantly improved in various research fields [25][26][27]. In 2018, the NC3Rs formed an international working group involving journal editors, researchers, and statisticians from a variety of fields with the aim of reviewing and updating the guidelines [28]. As a result, a revised version of the guidelines has recently been published (ARRIVE 2.0) [29].

    While the reasons the positive results obtained in preclinical studies for urethral repair have not been reproduced in the subsequent clinical trials are complex, poorly designed experiments and a lack of quality in reporting might be some of the main reasons that hinder clinical translation [30]. However, the quality of reporting in preclinical urethral tissue engineering studies remains unclear. Moreover, it is unknown if the quality of reporting has improved as a consequence of the introduction of the ARRIVE guidelines.

    2. Methodology

    Two separate searches were conducted in the databases MEDLINE of PubMed and EMBASE of OVID SP in March 2020. The search terms selected were as follows: rabbit, tissue engineering, stem cell, scaffolds, autologous graft, urethral graft, urethral reconstruction, regenerative medicine, reconstructive surgery, urethra, and animal experimentation. The search fields were controlled by database fields such as MeSH term, Text Word, and All Fields appropriate to the databases. “Publication date: 01/01/2014 to present” and “English language” filters were used. As the ARRIVE guidelines were first released in 2010, we selected to start our search in 2014, assuming that four years would allow the authors of preclinical studies sufficient time to plan, perform, and publish the results according to the guidelines. Details of the search are represented in the PRISMA flow diagram ( Figure 1 ).

    Figure 1. PRISMA flow chart to outline the inclusion process for the articles in this study.

    Extraction into a standardized data framework derived from the ARRIVE checklist [22] was conducted by two independent reviewers (A.K.P.S. and A.A.). The ARRIVE guideline consists of 20 items, some of which are further divided in subitems. For the purpose of this work, a list of 38 items was elaborated, which includes the items and subitems from the original ARRIVE guideline . Each of these 38 items was evaluated as “Yes” or “No” to indicate whether it was reported in the study or not. For some of the questions, a third option, “Not Applicable (N/A)”, was included to indicate items that were not relevant for the study (for example, in experiments employing only one experimental group, item 11a concerning allocation becomes N/A). Specific operational instructions were provided to both reviewers before they read the selected full-text articles and extracted the data blinded to the analysis from the other reviewer. A training phase through the detailed description and examples of scoring was conducted among the authors before the commencement of the data extraction. Inconsistent data were consequently settled by an additional independent researcher (T.A.).

    The data were compiled employing a Microsoft Excel spreadsheet and analyzed using IBM SPSS Statistics (version 21). For each of the selected studies, a score was calculated, which represents the percentage of positively reported items. The score was calculated using the following formula:

    1S c o r e = ( N y e s 38− N n a ) × 100 where Nyes = number of “Yes” entries, Nna = number of “Not Applicable” entries, and 38 is the total number of items in the ARRIVE guideline. The units of analysis were the individual articles when assessing the scores, and the single ARRIVE item when assessing their adherence across studies. A further analysis was performed to assess the adherence of the studies to several subitems within the ARRIVE checklist. A Mann–Kendall nonparametric test was used to assess whether the scores had a monotonic trend over the years. This is a simple, but robust non-parametric test that does not require the data to be normally distributed or follow a linear trend. The intraclass correlation coefficient (ICC) analysis was utilized to examine the inter-rater agreement between the two reviewers. The ICC was selected because it reflects both degree of correlation and agreement between measurements. ICC values <0.5 are indicative of poor reliability, 0.5–0.75 indicate moderate reliability, 0.75–0.9 indicate good reliability, and >0.90 indicate excellent reliability [31]. Statistical significance was set at p < 0.05.

    3. Results of Preclinical Urethral Tissue Engineering Studies

    As shown in Figure 1 , a total of 189 articles were initially screened after the literature search. Following the inclusion and exclusion criteria, a total of 43 studies were selected for full-text reading ( Figure 1 ). Only 28 studies were considered eligible for quality appraisal [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59]. These studies comprise a range of approaches and scaffolds for urethral repair in rabbits, which are summarized in the Supplementary Table S2 . The table provides details about the strain, sex, age, weight, number of animals, graft approach, material, and duration of the implantation. The numbers of rabbits in each experiment was 20 on average and ranged between 7 and 36, and the post-implantation follow-up duration was 5 months on average and varied between two weeks and nine months. All studies used male rabbits, except one study that included male and female animals. The most commonly studied approach was using acellular matrices as a patch (21 studies; length average (15 mm) range (5–20 mm)) versus tubes (7 studies; length average (20 mm) range (10–30 mm)).

    Figure 1. PRISMA flow chart to outline the inclusion process for the articles in this study.

    The scores for each of the checklist items are shown in Figure 2. The data were clustered into three groups to evidence the level of adherence to the guidelines of each of the 38 items in the checklist. While 34% of the items (13/38) appeared under the green category (agreement between 80 and 100%), 21% of the studies (8/38) appeared in the orange category (agreement between 50 and 79%), and 45% of the items (17/38) were associated with the red category (agreement between 0 and 49%).

    Figure 2. Bar chart showing the degree of adherence (in %) to the 38 items in the ARRIVE checklist. The data were clustered to display the items in which studies had a high degree of adherence (between 80 and 100%, in green), medium degree of adherence (between 50 and 79%, in yellow), and low degree of adherence (0 to 49%, in red). Items are indicated by their corresponding numbers and a label associated with their content.

    The items that attained the highest scores included the number of animals utilized, the size of experimental and control groups, and the definition of experimental outcomes. A description of the study background, including context and rationale, was also adequately provided in all of the studies. However, variables relevant to the reproducibility of the experiments were not often disclosed. The least frequently reported checklist items (only found in ≤10% of the studies) were items 18c (interpretation), 7b (experimental procedures), 17b (adverse events), 6c (experimental unit), 13b (analysis unit), 7d (procedure rational), 11b (animal allocation), 13c (statistical design), and 10b (sample size). These items are related to information on test methods, sample size calculation, statistical approaches, adverse events, and interpretation/scientific outcomes. Although statistical methods were disclosed and described in almost two-thirds of the articles, the statement of statistical methodology was frequently inadequate. Most articles did not include information about data distribution, definition of the unit of analysis, or justification for choosing a specific analytical method. Surprisingly, none of the articles disclosed the approach to verify that the assumptions for the statistical methods were met. Although every article described the experimental results, some of them failed in specifying the primary and secondary outcomes.

    The adherence of the studies to the different parts, rather than the overall item, is shown separately in a table format ( Table 1 ). Concerning the compliance to ethical standards, 92% of the analyzed studies stated that the protocol was approved and 89% referred to national or international guidelines ( Table 1 a). However, a complete ethical statement, disclosing both the approval of the protocol and guidelines followed, was only present in 46% of the studies. Concerning study design, there were various essential items that were poorly reported. While recording of randomization (6.b) scored 46%, none of the 28 studies reported sample size estimation or steps to reduce assessment bias ( Table 1 b). Regarding item 7a (experimental procedure), while it scored 96% owing to the majority of studies reporting surgical procedures and anesthesia, very few studies reported post-operative analgesia or euthanasia ( Table 1 c). Regarding the details of the animals, the most frequently reported information was the weight. However, only 14% of the studies provided the age of the animals ( Table 1 d). Details concerning the animal’s housing (9a) were infrequently listed (less than 30% of all studies). Only few studies reported the type of facility, cage, bedding material, or number of cage companions ( Table 1 e). Data about nutritional aspects and environment, such as temperature, humidity, and access to water and food, were also infrequently reported. No environmental enrichment was reported in any of the studies ( Table 1 f). In relation to the study limitations (18.b), most studies stated general limitations and potential sources of bias. However, only few articles addressed the limitations of the animal model or imprecision of the results ( Table 1 g).

    Table 1. Analysis of adherence of the studies to selected items in the checklist.
    (a) Item 5: Ethical statements Ratio %
    Refers to guidelines 25/28 89
    Approved protocol 26/28 92
    (b) Item 6b: Steps to minimize subjective bias in the study design    
    Random allocation 13/28 46
    Blind assessment 0/28 0
    (c) Item 7a: Information about experimental procedures    
    Surgical procedure 20/28 71
    Anesthesia 22/28 79
    Post-operative analgesia 4/28 14
    Method of euthanasia 4/28 14
    (d) Item 8a: Details about animals in the experimental design    
    Sex 28/28 100
    Weight and age 4/28 14
    Weight but not age 18/28 64
    Age but not weight 0/28 0
    (e) Item 9a: Information about housing conditions    
    Type of facility 5/28 18
    Type of cage 3/28 11
    Bedding material 1/28 4
    Number of cage companions 1/28 4
    (f) Item 9b: Information about nutritional aspects and environment    
    Access to water / food 3/28 11
    Breeding program 2/28 7
    Temperature/humidity 2/28 7
    Light/dark cycles 2/28 7
    Environmental enrichment 0/28 0
    (g) Item 18b: Disclosure of limitations in the results´ interpretation    
    General limitations, including potential sources of bias 21/28 75
    Limitations of the animal model 10/28 36
    Imprecision 8/28 29

    4. Conclusions

    Our study recognized that published animal experiments studying tissue engineering approaches for urethral repair display inadequate reporting of fundamental information. The quality of reporting improved only marginally over the study period. Inadequate reporting of the critical points of research experiments could remarkably affect the clarity, reproducibility, and translatability. We encourage the utilization of the ARRIVE checklist items when reporting preclinical studies to help the publication of manuscripts that would allow a precise judgment of their scientific merit. This has the potential to enhance both the translatability of the findings to humans and the fulfilment of the ethical requirements and further supports objective comparison between different studies.


    1. Santucci, R.A.; Joyce, G.F.; Wise, M. Male Urethral Stricture Disease. J. Urol. 2007, 177, 1667–1674.
    2. Mangir, N.; Wilson, K.J.; Osman, N.I.; Chapple, C.R. Current state of urethral tissue engineering. Curr. Opin. Urol. 2019, 29, 385–393.
    3. Keays, M.A.; Dave, S. Current hypospadias management: Diagnosis, surgical management, and long-term patient-centred outcomes. Can. Urol. Assoc. J. 2017, 11, S48–S53.
    4. Chapple, C.; Andrich, D.; Atala, A.; Barbagli, G.; Cavalcanti, A.; Kulkarni, S.; Mangera, A.; Nakajima, Y. SIU/ICUD Consultation on Urethral Strictures: The Management of Anterior Urethral Stricture Disease Using Substitution Urethroplasty. Urology 2014, 83, S31–S47.
    5. Snodgrass, W.; Bush, N. Primary hypospadias repair techniques: A review of the evidence. Urol. Ann. 2016, 8, 403–408.
    6. Barbagli, G.; Sansalone, S.; Djinovic, R.; Romano, G.; Lazzeri, M. Current controversies in reconstructive surgery of the anterior urethra: A clinical overview. Int. Braz. J. Urol. 2012, 38, 307–316.
    7. Mundy, A.R.; Andrich, D.E. Urethral strictures. BJU Int. 2011, 107, 6–26.
    8. Abbas, T.O.; Mahdi, E.; Hasan, A.; AlAnsari, A.; Pennisi, C.P. Current Status of Tissue Engineering in the Management of Severe Hypospadias. Front. Pediatr. 2018, 5, 283.
    9. Abbas, T.O.; Yalcin, H.C.; Pennisi, C.P. From Acellular Matrices to Smart Polymers: Degradable Scaffolds that are Transforming the Shape of Urethral Tissue Engineering. Int. J. Mol. Sci. 2019, 20, 1763.
    10. Versteegden, L.R.M.; de Jonge, P.K.J.D.; IntHout, J.; van Kuppevelt, T.H.; Oosterwijk, E.; Feitz, W.F.J.; de Vries, R.B.M.; Daamen, W.F. Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies. Eur. Urol. 2017, 72, 594–606.
    11. Sievert, K.-D. Tissue Engineering of the Urethra: Solid Basic Research and Farsighted Planning are Required for Clinical Application. Eur. Urol. 2017, 72, 607–609.
    12. Qi, N.; Li, W.; Tian, H. A Systematic Review of Animal and Clinical Studies on the Use of Scaffolds for Urethral Repair. Acta Acad. Med. Wuhan 2016, 36, 111–117.
    13. Rosito, T.E.; Pires, J.A.S.; Delcelo, R.; Ortiz, V.; Macedo Jr, A. Macroscopic and histological evaluation of tunica vaginalis dorsal grafting in the first stage of Bracka’s urethroplasty: An experimental study in rabbits. BJU Int. 2011, 108, E17–E22.
    14. Faydacı, G.; Tarhan, F.; Tuncer, M.; Eryıldırım, B.; Celik, O.; Keser, S.H.; Özgül, A. Comparison of Two Experimental Models for Urethral Stricture in the Anterior Urethra of the Male Rabbit. Urology 2012, 80, 225.e7–225.e11.
    15. Zhang, K.; Fu, Q.; Yoo, J.; Chen, X.; Chandra, P.; Mo, X.; Song, L.; Atala, A.; Zhao, W. 3D bioprinting of urethra with PCL/PLCL blend and dual autologous cells in fibrin hydrogel: An in vitro evaluation of biomimetic mechanical property and cell growth environment. Acta Biomater. 2017, 50, 154–164.
    16. Theodorescu, D.; Balcom, A.; Smith, C.; McLorie, G.; Churchill, B.; Khoury, A. Urethral replacement with vascularized tunica vaginalis: Defining the optimal form of use. J. Urol. 1998, 159, 1708–1711.
    17. Kemppainen, E.; Talja, M.; Riihelä, M.; Pohjonen, T.; Törmälä, P.; Alfthan, O. A bioresorbable urethral stent. An experimental study. Urol. Res. 1993, 21, 235–238. Available online: (accessed on 17 February 2021).
    18. Bradley, J.E.; Anderson, U.A.; Woolsey, S.M.; Thornbury, K.D.; McHale, N.G.; Hollywood, M.A. Characterization of T-type calcium current and its contribution to electrical activity in rabbit urethra. Am. J. Physiol. Cell Physiol. 2004, 286, C1078–C1088.
    19. Festing, M.F.W. The choice of animal model and reduction. Altern. Lab. Anim. 2004, 32 (Suppl. 2), 59–64. Available online: (accessed on 17 February 2021).
    20. Mignini, L.E.; Khan, K.S. Methodological quality of systematic reviews of animal studies: A survey of reviews of basic research. BMC Med. Res. Methodol. 2006, 6, 10.
    21. Korevaar, D.A.; Hooft, L.; Ter Riet, G. Systematic reviews and meta-analyses of preclinical studies: Publication bias in laboratory animal experiments. Lab. Anim. 2011, 45, 225–230.
    22. Kilkenny, C.; Browne, W.J.; Cuthill, I.C.; Emerson, M.; Altman, D.G. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8, e1000412.
    23. Kilkenny, C.; Browne, W.; Cuthill, I.C.; Emerson, M.; Altman, D.G. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br. J. Pharmacol. 2010, 160, 1577–1579.
    24. van der Worp, H.B.; Howells, D.W.; Sena, E.S.; Porritt, M.J.; Rewell, S.; O’Collins, V.; Macleod, M.R. Can Animal Models of Disease Reliably Inform Human Studies? PLoS Med. 2010, 7, e1000245.
    25. Leung, V.; Rousseau-Blass, F.; Beauchamp, G.; Pang, D.S.J. ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia. PLoS ONE 2018, 13, e0197882.
    26. Bezdjian, A.; Klis, S.F.L.; Peters, J.P.M.; Grolman, W.; Stegeman, I. Quality of reporting of otorhinolaryngology articles using animal models with the ARRIVE statement. Lab. Anim. 2018, 52, 79–87.
    27. Ting, K.H.J.; Hill, C.L.; Whittle, S.L. Quality of reporting of interventional animal studies in rheumatology: A systematic review using the ARRIVE guidelines. Int. J. Rheum. Dis. 2015, 18, 488–494.
    28. Percie du Sert, N.; Hurst, V.; Ahluwalia, A.; Alam, S.; Altman, D.G.; Avey, M.T.; Baker, M.; Browne, W.; Clark, A.; Cuthill, I.C.; et al. Revision of the ARRIVE guidelines: Rationale and scope. BMJ Open Sci. 2018, 2, e000002.
    29. Percie du Sert, N.; Hurst, V.; Ahluwalia, A.; Alam, S.; Avey, M.T.; Baker, M.; Browne, W.J.; Clark, A.; Cuthill, I.C.; Dirnagl, U.; et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. BMC Vet. Res. 2020, 16, 242.
    30. Collins, F.S.; Tabak, L.A. Policy: NIH plans to enhance reproducibility. Nature 2014, 505, 612–613.
    31. Koo, T.K.; Li, M.Y. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J. Chiropr. Med. 2016, 15, 155–163.
    32. Huang, J.-W.; Xie, M.-K.; Zhang, Y.; Wei, G.-J.; Li, X.; Li, H.-B.; Wang, J.-H.; Zhu, W.-D.; Li, C.; Xu, Y.-M.; et al. Reconstruction of Penile Urethra With the 3-Dimensional Porous Bladder Acellular Matrix in a Rabbit Model. Urology 2014, 84, 1499–1505.
    33. Li, H.; Xu, Y.; Xie, H.; Li, C.; Song, L.; Feng, C.; Zhang, Q.; Xie, M.; Wang, Y.; Lv, X. Epithelial-differentiated adipose-derived stem cells seeded bladder acellular matrix grafts for urethral reconstruction: An animal model. Tissue Eng. Part A 2014, 20, 774–784.
    34. Wang, F.; Liu, T.; Yang, L.; Zhang, G.; Liu, H.; Yi, X.; Yang, X.; Lin, T.; Qin, W.; Yuan, J. Urethral reconstruction with tissue-engineered human amniotic scaffold in rabbit urethral injury models. Med. Sci. Monit. 2014, 20, 2430–2438.
    35. Kajbafzadeh, A.-M.; Sabetkish, S.; Tourchi, A.; Amirizadeh, N.; Afshar, K.; Abolghasemi, H.; Elmi, A.; Talab, S.S.; Eshghi, P.; Mohseni, M.J. The application of tissue-engineered preputial matrix and fibrin sealant for urethral reconstruction in rabbit model. Int. Urol. Nephrol. 2014, 46, 1573–1580.
    36. Sun, D.; Yang, Y.; Wei, Z.; Xu, Y.; Zhang, X.; Hong, B. Engineering of pre-vascularized urethral patch with muscle flaps and hypoxia-activated hUCMSCs improves its therapeutic outcome. J. Cell. Mol. Med. 2014, 18, 434–443.
    37. Xu, Y.; Sun, D.C.; Wei, Z.T.; Hong, B.F.; Yang, Y. Experimental study on transplantation of autologous minced muscle with human umbilical cord mesenchymal stem cells for urethral reconstruction. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 3412–3419. Available online: (accessed on 17 February 2021).
    38. Arenas da Silva, L.F.; Micol, L.; Tiemessen, D.; van Kuppevelt, T.H.; Frey, P.; Oosterwijk, E.; Geutjes, P.; Feitz, W.F. Is There a Need for Smooth Muscle Cell Transplantation in Urethral Reconstruction? Tissue Eng. Part A 2014, 20, 1542–1549.
    39. Chun, S.Y.; Kim, B.S.; Kwon, S.Y.; Park, S.I.; Song, P.H.; Yoo, E.S.; Kim, B.W.; Kwon, T.G.; Kim, H.T. Urethroplasty using autologous urethral tissue-embedded acellular porcine bladder submucosa matrix grafts for the management of long-segment urethral stricture in a rabbit model. J. Korean Med. Sci. 2015, 30, 301–307.
    40. Guo, H.; Sa, Y.; Huang, J.; Wang, Z.; Wang, L.; Xie, M.; Lv, X. Urethral Reconstruction with Small Intestinal Submucosa Seeded with Oral Keratinocytes and TIMP-1 siRNA Transfected Fibroblasts in a Rabbit Model. Urol. Int. 2016, 96, 223–230.
    41. Huang, J.-W.; Lv, X.-G.; Li, Z.; Song, L.-J.; Feng, C.; Xie, M.-K.; Li, C.; Li, H.-B.; Wang, J.-H.; Zhu, W.-D.; et al. Urethral reconstruction with a 3D porous bacterial cellulose scaffold seeded with lingual keratinocytes in a rabbit model. Biomed. Mater. 2015, 10, 055005.
    42. Zhang, K.; Guo, X.; Zhao, W.; Niu, G.; Mo, X.; Fu, Q. Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study. Int. J. Mol. Sci. 2015, 16, 27659–27676.
    43. Wang, D.; Li, M.; Huang, W.; Lu, M.; Hu, C.; Li, K.; Qiu, J.; Gao, X. Repair of urethral defects with polylactid acid fibrous membrane seeded with adipose-derived stem cells in a rabbit model. Connect. Tissue Res. 2015, 56, 434–439.
    44. Rogovaya, O.S.; Fayzulin, A.K.; Vasiliev, A.V.; Kononov, A.V.; Terskikh, V. V Reconstruction of rabbit urethral epithelium with skin keratinocytes. Acta Naturae 2015, 7, 70–77. Available online: (accessed on 17 February 2021).
    45. Lv, X.; Li, Z.; Chen, S.; Xie, M.; Huang, J.; Peng, X.; Yang, R.; Wang, H.; Xu, Y.; Feng, C. Structural and functional evaluation of oxygenating keratin/silk fibroin scaffold and initial assessment of their potential for urethral tissue engineering. Biomaterials 2016, 84, 99–110.
    46. Lv, X.; Guo, Q.; Han, F.; Chen, C.; Ling, C.; Chen, W.; Li, B. Electrospun Poly(l-lactide)/Poly(ethylene glycol) Scaffolds Seeded with Human Amniotic Mesenchymal Stem Cells for Urethral Epithelium Repair. Int. J. Mol. Sci. 2016, 17, 1262.
    47. Pinnagoda, K.; Larsson, H.M.; Vythilingam, G.; Vardar, E.; Engelhardt, E.-M.; Thambidorai, R.C.; Hubbell, J.A.; Frey, P. Engineered acellular collagen scaffold for endogenous cell guidance, a novel approach in urethral regeneration. Acta Biomater. 2016, 43, 208–217.
    48. Güneş, M.; Altok, M.; Güneş, A.; Umul, M.; Özyıldız, Z.; Sönmez, T.T.; Orhan, H.; Özmen, Ö. A Novel Approach to Penile Augmentation Urethroplasty Using Buccal Mucosa and Amniotic Membrane: A Pilot Study in a Rabbit Model. Urology 2016, 87, 210–215.
    49. Nikolavsky, D.; Manwaring, J.; Bratslavsky, G.; Caza, T.; Landas, S.; Hryniewicz-Jankowska, A.; Kotula, L. Novel Concept and Method of Endoscopic Urethral Stricture Treatment Using Liquid Buccal Mucosal Graft. J. Urol. 2016, 196, 1788–1795.
    50. Liu, Y.; Ma, W.; Liu, B.; Wang, Y.; Chu, J.; Xiong, G.; Shen, L.; Long, C.; Lin, T.; He, D.; et al. Urethral reconstruction with autologous urine-derived stem cells seeded in three-dimensional porous small intestinal submucosa in a rabbit model. Stem Cell Res. Ther. 2017, 8, 1943–1949.
    51. Jiang, S.; Xu, Z.; Zhao, Y.; Yan, L.; Zhou, Z.; Gu, G. Urethral Reconstruction Using Mesothelial Cell-Seeded Autogenous Granulation Tissue Tube: An Experimental Study in Male Rabbits. Biomed Res. Int. 2017, 2017, 1–9.
    52. Larsson, H.M.; Vythilingam, G.; Pinnagoda, K.; Vardar, E.; Engelhardt, E.M.; Sothilingam, S.; Thambidorai, R.C.; Kamarul, T.; Hubbell, J.A.; Frey, P. Fiber density of collagen grafts impacts rabbit urethral regeneration. Sci. Rep. 2018, 8, 10057.
    53. Algarrahi, K.; Affas, S.; Sack, B.S.; Yang, X.; Costa, K.; Seager, C.; Estrada, C.R.; Mauney, J.R. Repair of injured urethras with silk fibroin scaffolds in a rabbit model of onlay urethroplasty. J. Surg. Res. 2018, 229, 192–199.
    54. Sa, Y.; Wang, L.; Shu, H.; Gu, J. Post-transcriptional suppression of TIMP-1 in epithelial-differentiated adipose-derived stem cells seeded bladder acellular matrix grafts reduces urethral scar formation. Artif. Cells Nanomed. Biotechnol. 2018, 46, 306–313.
    55. Sartoneva, R.; Nordback, P.H.; Haimi, S.; Grijpma, D.W.; Lehto, K.; Rooney, N.; Seppänen-Kaijansinkko, R.; Miettinen, S.; Lahdes-Vasama, T. Comparison of Poly(l-lactide-co-ε-caprolactone) and Poly(trimethylene carbonate) Membranes for Urethral Regeneration: An In Vitro and In Vivo Study. Tissue Eng. Part A 2018, 24, 117–127.
    56. Pusateri, C.R.; Doudt, A.D.; Gauerke, S.; McCammon, K.; Qin, X.; Ork, B.; Khoury, J.M.; May, A.D.; Zuckerman, J.M. Placental membrane grafts for urethral replacement in a rabbit model: A pilot study. World J. Urol. 2019, 38, 2133–2138.
    57. Guo, H.-L.; Jia, Z.-M.; Wang, L.; Bao, X.-Q.; Huang, Y.-C.; Zhou, J.-M.; Xie, H.; Yang, X.-J.; Chen, F. Tubularized urethral reconstruction using a prevascularized capsular tissue prelaminated with buccal mucosa graft in a rabbit model. Asian J. Androl. 2019, 21, 381–386.
    58. Hua, X.; Chen, J.; Xu, Y.; Li, B. Combined Dorsal Plus Ventral Double Tunica Vaginalis Graft Urethroplasty: An Experimental Study in Rabbits. Urology 2019, 126, 209–216.
    59. Li, Y.; Wu, J.; Feng, F.; Men, C.; Yang, D.; Gao, Z.; Zhu, Z.; Cui, Y.; Zhao, H. A Preclinical Study of Cell-seeded Tubularized Scaffolds Specially Secreting LL37 for Reconstruction of Long Urethral Defects. Anticancer Res. 2017, 37, 4295–4301.
    Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
    View Times: 291
    Revisions: 2 times (View History)
    Update Date: 10 Sep 2021
    Table of Contents


      Are you sure to Delete?

      Video Upload Options

      Do you have a full video?
      If you have any further questions, please contact Encyclopedia Editorial Office.
      Abbas, T. Preclinical Urethral Tissue Engineering Studies. Encyclopedia. Available online: (accessed on 24 September 2023).
      Abbas T. Preclinical Urethral Tissue Engineering Studies. Encyclopedia. Available at: Accessed September 24, 2023.
      Abbas, Tariq. "Preclinical Urethral Tissue Engineering Studies" Encyclopedia, (accessed September 24, 2023).
      Abbas, T.(2021, September 10). Preclinical Urethral Tissue Engineering Studies. In Encyclopedia.
      Abbas, Tariq. "Preclinical Urethral Tissue Engineering Studies." Encyclopedia. Web. 10 September, 2021.